Effects of endocrine disruptors in the development of the female reproductive tract

Carregando...
Imagem de Miniatura
Citações na Scopus
84
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
Autores
SPRITZER, Poli Mara
HOHL, Alexandre
Citação
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, v.58, n.2, Special Issue, p.153-161, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Environmental agencies have identified a growing number of environmental contaminants that have endocrine disrupting activity, and these can become a major public health problem. It is suggested that endocrine disruptors could account for the higher-than-expected increase in the prevalence of some non-communicable diseases, such as obesity, diabetes, thyroid diseases, and some cancers. Several endocrine Disrupting Chemicals (EDCs), such as pesticides, bisphenol A, phthalates, dioxins, and phytoestrogens, can interact with the female reproductive system and lead to endocrine disruption. Initially, it was assumed that EDCs exert their effects by binding to hormone receptors and transcription factors, but it is currently known that they may also alter the expression of enzymes involved in the synthesis or catabolism of steroids. Biomonitoring studies have identified these compounds in adults, children, pregnant women, and fetuses. Among the diseases of the female reproductive tract associated with EDCs exposure are the following: precocious puberty, polycystic ovary syndrome, and premature ovarian failure. The different populations of the world are exposed to a great number of chemicals through different routes of infection; despite the various available studies, there is still much doubt regarding the additive effect of a mixture of EDCs with similar mechanisms of action.
Palavras-chave
Endocrine disruptors, female development, precocious puberty, polycystic ovary syndrome, premature ovarian failure
Referências
  1. Ahn HJ, 2012, MOL REPROD DEV, V79, P626, DOI 10.1002/mrd.22070
  2. Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8451
  3. Axmon A, 2004, CHEMOSPHERE, V56, P813, DOI 10.1016/j.chemosphere.2004.03.002
  4. Bachega TASS, 2011, ARQ BRAS ENDOCRINOL, V55, P175, DOI 10.1590/S0004-27302011000200011
  5. Bastos AMX, 2013, ARQ BRAS ENDOCRINOL, V57, P346, DOI 10.1590/S0004-27302013000500003
  6. Bigsby R, 1999, ENVIRON HEALTH PERSP, V107, P613, DOI 10.2307/3434553
  7. Brieno-Enriquez MA, 2012, MOL HUM REPROD, V18, P171, DOI 10.1093/molehr/gar074
  8. Buttke DE, 2012, ENVIRON HEALTH PERSP, V120, P1613, DOI 10.1289/ehp.1104748
  9. Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200
  10. Chang JW, 2010, EPIDEMIOLOGY, V21, P56, DOI 10.1097/EDE.0b013e3181c2fc6e
  11. Chao HR, 2007, FOOD CHEM TOXICOL, V45, P259, DOI 10.1016/j.fct.2006.07.032
  12. Christensen Brock C, 2011, Front Genet, V2, P84, DOI 10.3389/fgene.2011.00084
  13. Cooper AR, 2011, FERTIL STERIL, V95, P1890, DOI 10.1016/j.fertnstert.2010.01.016
  14. Costa EMF, 2013, PROENDOCRINO, V4
  15. Cummings AM, 1997, CRIT REV TOXICOL, V27, P367, DOI 10.3109/10408449709089899
  16. Decherf S, 2011, J TOXICOL ENV HEAL B, V14, P423, DOI 10.1080/10937404.2011.578561
  17. Diamanti-Kandarakis E, 2008, CLIN ENDOCRINOL, V69, P634, DOI 10.1111/j.1365-2265.2008.03247.x
  18. Diamanti-Kandarakis E, 2009, EUR J ENDOCRINOL, V160, P847, DOI 10.1530/EJE-08-0510
  19. Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002
  20. Eichenlaub-Ritter U, 2008, MUTAT RES-GEN TOX EN, V651, P82, DOI 10.1016/j.mrgentox.2007.10.014
  21. Farr SL, 2004, AM J EPIDEMIOL, V160, P1194, DOI 10.1093/aje/kwi006
  22. Fernandez M, 2010, ENVIRON HEALTH PERSP, V118, P1217, DOI 10.1289/ehp.0901257
  23. Fortes EM, 2007, ARQ BRAS ENDOCRINOL, V51, P500, DOI 10.1590/S0004-27302007000300021
  24. Gaido KW, 2000, MOL PHARMACOL, V58, P852
  25. GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198
  26. Hanioka N, 1998, ARCH TOXICOL, V72, P387, DOI 10.1007/s002040050518
  27. Hao CJ, 2012, BIOSCIENCE REP, V32, P619, DOI 10.1042/BSR20120042
  28. Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015
  29. Hoyer PB, 2001, TOXICOL PATHOL, V29, P91, DOI 10.1080/019262301301418892
  30. Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1
  31. Jinno M, 2011, HUM REPROD, V26, P604, DOI 10.1093/humrep/deq388
  32. Kandaraki E, 2011, J CLIN ENDOCR METAB, V96, pE480, DOI 10.1210/jc.2010-1658
  33. Kappeler CJ, 2012, SYST BIOL REPROD MED, V58, P57, DOI 10.3109/19396368.2011.648820
  34. Kirigaya A, 2009, ZOOL SCI, V26, P704, DOI 10.2108/zsj.26.704
  35. Liem AKD, 2000, FOOD ADDIT CONTAM, V17, P241, DOI 10.1080/026520300283324
  36. MARTINEZ EM, 1991, REPROD TOXICOL, V5, P139, DOI 10.1016/0890-6238(91)90042-E
  37. Mouritsen A, 2010, INT J ANDROL, V33, P346, DOI 10.1111/j.1365-2605.2010.01051.x
  38. Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697
  39. Newbold RR, 2004, TOXICOL APPL PHARM, V199, P142, DOI 10.1016/j.taap.2003.11.033
  40. Newbold RR, 2009, ENVIRON HEALTH PERSP, V117, P879, DOI 10.1289/ehp.0800045
  41. Nikaido Y, 2004, REPROD TOXICOL, V18, P803, DOI 10.1016/j.reprotox.2004.05.002
  42. Pasquali R, 2011, CLIN ENDOCRINOL, V74, P424, DOI 10.1111/j.1365-2265.2010.03956.x
  43. Patisaul HB, 2013, ADV EXP MED BIOL, V784, P455, DOI 10.1007/978-1-4614-6199-9_21
  44. Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189
  45. Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007
  46. Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165
  47. Uribarri J, 2006, CLIN J AM SOC NEPHRO, V1, P1293, DOI 10.2215/CJN.01270406
  48. Zhou W, 2008, MOL CELL ENDOCRINOL, V283, P12, DOI 10.1016/j.mce.2007.10.010
  49. Zoeller RT, 2006, ENDOCRINOLOGY, V147, P5513, DOI 10.1210/en.2006-1282